gaithersburg semaglutide & tirzepatide EASD 2023: meta-analysis shows superiority to Tirzepatide Tops Semaglutide for Weight

The global market for GLP-1 drugs is expected to grow rapidly over the next decade, from $62.9 billion last year to $315.3 billion by 2035, according to India-based health care consulting firm Towards Healthcare

These incretin mimetic GLP-1 and GIP/GLP-1 drugs that help you lose body weight by slowing down digestion and increasing the transit time of food in the stomach have gained widespread popularity in the past half a decade

In addition to being an epidemic, obesity is also a chronic disease

Private treatment offers potentially faster access but at substantial cost

RETA treatment also resulted in striking improvements in systemic metabolism with a significant reduction in fasted blood glucose concentrations

Science 336 , 1262 (2012)